The present study reports the synthesis of benzylpyrazolyl naphthoquinones using nano-Fe3O4 supported Bronsted acidic ionic liquid ([nano-Fe3O4@BenzImi]SO3H) as magnetically retrievable solid acid catalyst. In vitro anti-cancer activity of the synthesized benzylpyrazolyl naphthoquinones have been evaluated against breast cancer cell line (MCF-7) and liver cancer cell line (HepG2). Compound 4h was found to be the most active compounds with IC50 values 0.0436 +/- 0.31 mu M against MCF 7 cell line whereas compound 4e was displayed highest activity with IC50 values 0.0314 +/- 0.16 mu M against HepG2 cell line as compared to the standard 5-fluorouracil (0.0384 +/- 0.10 and 0.0330 +/- 0.09 mu M). Furthermore, in silico bioactivity studies revealed that the compounds have significant interactions with the drug targets. The molecular docking studies revealed that the compounds have significant binding affinity with potential receptors such as vascular endothelial growth factor receptor (VEGFR-2), G-protein coupled receptor (GPCR) and peroxisome proliferator-activated receptors (PPAR). The compound 4g has strong hydrogen bond interaction with VEGFR-2 as well as the lowest binding energy (-9.3 kcal/mol-1), similarly, 4c has strong hydrogen bond interaction with in GPCR as well as the lowest binding energy (-7.8 kcal/mol-1) whereas 4a and 4e show strong hydrogen bond interaction with in PPAR as well as lowest binding energy (-10.1 kcal/mol- 1 and -10.1 kcal/mol- 1) as compared to other compounds. The docking studies revealed that these compounds gets stabilized via hydrogen bonding interactions, van der Waals contacts and electrostatic interactions which were further supported through estimation of HOMO-LUMO energies, ionization potential, electron affinities, dipole moment etc. using density functional theory (DFT) analysis. The work highlights biological significance of benzylpyrazolyl naphthoquinones as a potential anti-cancer reagent.
机构:
Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing Key Lab Environm & Viral Oncol, Pingleyuan St 100, Beijing 100124, Peoples R ChinaBeijing Univ Technol, Coll Life Sci & Bioengn, Beijing Key Lab Environm & Viral Oncol, Pingleyuan St 100, Beijing 100124, Peoples R China
Sun, Wuji
Fang, Shubiao
论文数: 0引用数: 0
h-index: 0
机构:
Tong Yi Tang Pharmaceut Co Ltd, Suian Ind Pk Zhangpu Cty, Zhangzhou 363200, Fujian, Peoples R ChinaBeijing Univ Technol, Coll Life Sci & Bioengn, Beijing Key Lab Environm & Viral Oncol, Pingleyuan St 100, Beijing 100124, Peoples R China
Fang, Shubiao
Yan, Hong
论文数: 0引用数: 0
h-index: 0
机构:
Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing Key Lab Environm & Viral Oncol, Pingleyuan St 100, Beijing 100124, Peoples R ChinaBeijing Univ Technol, Coll Life Sci & Bioengn, Beijing Key Lab Environm & Viral Oncol, Pingleyuan St 100, Beijing 100124, Peoples R China
机构:
Al Azhar Univ, Pharmaceut Med Chem & Drug Design Dept, Fac Pharm Boys, Cairo 11884, EgyptKing Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia
Eissa, Ibrahim H.
Alsaif, Nawaf A.
论文数: 0引用数: 0
h-index: 0
机构:
King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi ArabiaKing Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia
Alsaif, Nawaf A.
Obaidullah, Ahmad J.
论文数: 0引用数: 0
h-index: 0
机构:
King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi ArabiaKing Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia
Obaidullah, Ahmad J.
Alanazi, Wael A.
论文数: 0引用数: 0
h-index: 0
机构:
King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi ArabiaKing Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia
Alanazi, Wael A.
Alasmari, Abdullah F.
论文数: 0引用数: 0
h-index: 0
机构:
King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi ArabiaKing Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia
机构:
Badr Univ Cairo BUC, Fac Pharm, Biochem Dept, Badr, EgyptAl Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chem & Drug Design Dept, Cairo 11884, Egypt
Doghish, Ahmed S.
论文数: 引用数:
h-index:
机构:
Ismail, Ahmed
Taghour, Mohammed S.
论文数: 0引用数: 0
h-index: 0
机构:
Al Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chem & Drug Design Dept, Cairo 11884, EgyptAl Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chem & Drug Design Dept, Cairo 11884, Egypt
Taghour, Mohammed S.
Elkaeed, Eslam B.
论文数: 0引用数: 0
h-index: 0
机构:
AlMaarefa Univ, Coll Pharm, Dept Pharmaceut Sci, Riyadh, Saudi ArabiaAl Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chem & Drug Design Dept, Cairo 11884, Egypt
Elkaeed, Eslam B.
Eissa, Ibrahim H.
论文数: 0引用数: 0
h-index: 0
机构:
Al Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chem & Drug Design Dept, Cairo 11884, EgyptAl Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chem & Drug Design Dept, Cairo 11884, Egypt
Eissa, Ibrahim H.
Dahab, Mohammed A.
论文数: 0引用数: 0
h-index: 0
机构:
Al Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chem & Drug Design Dept, Cairo 11884, EgyptAl Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chem & Drug Design Dept, Cairo 11884, Egypt
Dahab, Mohammed A.
Mahdy, Hazem A.
论文数: 0引用数: 0
h-index: 0
机构:
Al Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chem & Drug Design Dept, Cairo 11884, EgyptAl Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chem & Drug Design Dept, Cairo 11884, Egypt
Mahdy, Hazem A.
Khalifa, Mohamed M.
论文数: 0引用数: 0
h-index: 0
机构:
Al Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chem & Drug Design Dept, Cairo 11884, EgyptAl Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chem & Drug Design Dept, Cairo 11884, Egypt
机构:
Capital Med Univ, Beijing Shijitan Hosp, Phase Clin Trial Ctr 1, Beijing, Peoples R ChinaCapital Med Univ, Beijing Shijitan Hosp, Phase Clin Trial Ctr 1, Beijing, Peoples R China
Dong, Junmin
Hao, Xiaohua
论文数: 0引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Phase Clin Trial Ctr 1, Beijing, Peoples R ChinaCapital Med Univ, Beijing Shijitan Hosp, Phase Clin Trial Ctr 1, Beijing, Peoples R China